首页 > 产品目录 > 免疫学 > 抗体 > Anti-ORC4L antibody

Anti-ORC4L antibody

产品编号 :
英文名称 :
中文名称 :
产品等级 :
品牌 :
包装规格 交货周期 质量标准 目录价 会员专享价 数量
100ug
- +
产品详情
  • 产品名称

    Anti-ORC4L抗体
    参阅全部 ORC4L 一抗

  • 描述

    山羊多克隆抗体to ORC4L

  • 宿主

    Goat

  • 经测试应用

    适用于: WBmore details

  • 种属反应性

    与反应: Mouse, Rat, Human
    预测可用于: Cow, Dog

  • 免疫原

    Synthetic peptide corresponding to Human ORC4L aa 400-500 (C terminal). (NP_001177810.1; NP_001177811.1)
    Database link: 
    NP_002543.2

    Run BLAST with BLAST the sequence with ExPASyRun BLAST with BLAST the sequence with NCBI

  • 常规说明


    The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing this with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation. Please check that this product meets your needs before purchasing.

    If you have any questions, special requirements or concerns, please send us an inquiry and/or contact our Support team ahead of purchase. Recommended alternatives for this product can be found below, along with publications, customer reviews and Q&As

  • 形式

    Liquid

  • 存放说明

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.

  • 存储溶液

    pH: 7.30
    Preservative: 0.02% Sodium azide
    Constituents: Tris buffered saline, 0.5% BSA

  • 浓度

    • 100 µg 浓度为 0.5 mg/ml

  • 纯度

    Immunogen affinity purified

  • 纯化说明

    Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

  • 克隆

    多克隆

  • 同种型

    IgG

The Abpromise guarantee

Abpromise™承诺保证使用ab9641于以下的经测试应用

“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。

应用Ab评论说明
WB

Use a concentration of 0.5 - 2 µg/ml. Detects a band of approximately 50 kDa (predicted molecular weight: 50 kDa). 

1 hour primary incubation is recommended for this product.

数据库链接

别名

  • Origin recognition complex, subunit 4, S. cerevisiae, homolog of antibody

  • FLJ46668 antibody

  • HSORC4 antibody

  • ORC 4 antibody

  • ORC 4L antibody

  • ORC 4P antibody

  • ORC4 antibody

  • ORC4_HUMAN antibody

  • ORC4L antibody

  • ORC4L protein antibody

  • ORC4P antibody

  • Origin recognition complex subunit 4 (yeast homolog) like antibody

  • Origin recognition complex subunit 4 antibody

  • Origin recognition complex subunit 4 like (yeast) antibody

  • Origin recognition complex subunit 4 like antibody

  • origin recognition complex, subunit 4 homolog antibody

  • Origin recognition complex, subunit 4, S. cerevisiae, homolog-like antibody

  • Western blot - Anti-ORC4L antibody - ChIP Grade (ab9641)

    Western blot - Anti-ORC4L antibody - ChIP Grade (ab9641)

    Anti-ORC4L antibody (ab9641) at 0.5 µg/ml + Mouse heart lysate at 35 µg

    Predicted band size: 50 kDa

  • Western blot - Anti-ORC4L antibody - ChIP Grade (ab9641)

    Western blot - Anti-ORC4L antibody - ChIP Grade (ab9641)

    Anti-ORC4L antibody (ab9641) at 0.5 µg/ml + Rat Heart lysate in RIPA buffer at 35 µg

    Developed using the ECL technique.

    Predicted band size: 50 kDa
    Observed band size: 50 kDa

  • Western blot - Anti-ORC4L antibody - ChIP Grade (ab9641)

    Western blot - Anti-ORC4L antibody - ChIP Grade (ab9641)

    ab9641 (2µg/ml) staining of Jurkat lysate (RIPA buffer, 1.4E5 cells per lane). Detected by western blot using chemiluminescence.

  • Western blot - Anti-ORC4L antibody - ChIP Grade (ab9641)

    Western blot - Anti-ORC4L antibody - ChIP Grade (ab9641)

    All lanes : Anti-ORC4L antibody (ab9641) at 1 µg/ml

    Lane 1 : Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate
    Lane 2 : HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate
    Lane 3 : HEK293 (Human embryonic kidney cell line) Whole Cell Lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : Rabbit polyclonal to Goat IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

    Developed using the ECL technique.

    Performed under reducing conditions.

    Predicted band size: 50 kDa
    Observed band size: 49 kDa
    why is the actual band size different from the predicted?
    Additional bands at: 38 kDa. We are unsure as to the identity of these extra bands.


    Exposure time: 20 minutes